A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Panorama is shining a light on the use of weight loss medications - including Wegovy - in the UK. The BBC investigation programme is investigating anti-obesity drugs being used and asking the ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

also includes Wegovy and Zepbound. GLP-1s were developed to treat diabetes, but they have become popular weight-loss medications. MORE: In Kensington, outreach workers give out food, clothing and ...

Charlotte, 50, an Events Manager, embarked on The Slimming Clinic's weight loss programme and began using a Wegovy pen to assist ... The Slimming Clinic, I say: do it, you won't regret it.

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

A study has suggested that weight-loss injections may be linked to broader ... discovered that participants who used drugs such as Wegovy and Ozempic had a lower risk of 42 health conditions ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other ... Medicare drug plans do not cover drugs for obesity but ...